Hypermethylation-Associated Silencing of miR-125a and miR-125b: A Potential Marker in Colorectal Cancer

Table 1

Clinicopathological features of CRC patients and BSP analysis of miR-125a in tumor tissues.

Variable	Hypermethylation and low expression	Hypermethylation and high expression	Methylation and low expression	Methylation and high expression	value
Sex					0.686
Male (46)	38	2	1	5
Female (22)	17	1	1	3
Age (years)					0.343
50 (16)	13	1	0	2
50 (52)	42	2	2	6
Histological differentiation					1.000
Good or moderate	31	1	1	6
Poor or none	24	2	1	2
Lymph node metastasis					0.686
Negative	28	1	1	8
Positive	24	2	1	3
Grade					0.886
Low grade (I + II)	25	1	1	8
High grade (III + IV)	30	2	1	0